| Effect and safety of Semaglutide in diabetic kidney transplant recipients with obesity |
Ongoing |
Risankizumab |
3 |
M23-784 |
Aseer Central Hospital (Abha), International Medical Center (Jeddah), King Khalid University Hospital (Riyadh) |
| A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Participants with Sickle Cell Disease and an Open-Label Pharmacokinetics Study in Pediatric Participants with Sickle Cell Disease |
Ongoing |
Osivelotor |
2/3 |
C5351004 (GBT021601) |
Prince Mohammad Bin Naser Hospital (Jazan), King Abdulaziz Medical City NG (Riyadh) |
| INTERnational STudy Evaluating Lupus Outcomes after Anifrolumab Real-World Use (INTERSTELLAR): Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice |
Ongoing |
Semaglutide |
3 |
2241130 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| Effect and safety of Semaglutide in diabetic kidney transplant recipients with obesity |
Ongoing |
Anifrolumab |
3 |
2241130 |
Aseer Central Hospital (Abha), International Medical Center (Jeddah), King Khalid University Hospital (Riyadh) |
| Survey assessing prospective patient’s short-term treatment satisfaction and Quality of Life in patients with Hidradenitis Suppurativa initiated on Cosentyx (Secukinumab) in routine clinical practice in Saudi Arabia |
Ongoing |
Secukinumab |
4 |
CAIN457MSA |
King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| Comparing the effectiveness of buccal infiltration of different volumes of Articaine for extraction of mandibular posterior teeth- A randomized clinical trial. |
Ongoing |
ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE |
4 |
6074514624 |
Dental Clinic-collage of Dentistry-Qassim Unviersity (Al-Qassim) |
| The ENERGY 2 Study: An Open-Label Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Infants with Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency |
Ongoing |
INZ-701 |
3 |
INZ701-105 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod IV in Adult Participants With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis |
Ongoing |
Efgartigimod IV |
3 |
ARGX-113-2308 |
King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh) |
| INTERnational STudy Evaluating Lupus Outcomes after Anifrolumab Real-World Use (INTERSTELLAR): Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice |
Ongoing |
Anifrolumab |
4 |
TMP-0010230 |
Aseer Central Hospital (Abha), International Medical Center (Jeddah),King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah) |
| A prospective, randomized, double-blind, multicenter, placebo-controlled, parallel group, adaptive Phase 3 study with open-label extension to evaluate efficacy and safety of macitentan 75 mg in inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension. |
Terminated |
Macitentan (ACT-064992, Opsumit ®) |
3 |
67896062CTP3001 |
King Fahad Medical City (Riyadh),King Faisal Specialist Hospital and Research Center (Riyadh) |
